Malignant tumor of prostate (disorder)
REQUITE
Year Started: 2013
Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors
- Access:
- Access restricted at present
- Type:
- Disease specific
- Status:
- Completed
- Collection point:
- Pre-diagnosis
- Consent restrictions:
- No restrictions
Male
Adult (> 40 years)
1001 - 3000 donors
| Material Type | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|
| DNA | -60 °C to -85 °C | Not applicable | 100% |
| Whole blood | -60 °C to -85 °C | Not applicable | 100% |